Gabriel Galvão Rafael Magalhães

Gabriel Galvão Rafael Magalhães

Auto-generated profile, based on publicly available information

Gabriel Galvão Rafael Magalhães

Rede SARAH Hosp Reabilitacao, Ambulatorio Osteometabol, Brasilia, DF, Brazil

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 April 2022 in Archives of Endocrinology and Metabolism
Verified
Journal Article
Open access
PDF file
LVLuciana Pinto Valadares
Luciana Pinto Valadares
BFBruno Silva de Araújo Ferreira
Bruno Silva de Araújo Ferreira
BCBernardo Matos da Cunha
Bernardo Matos da Cunha
LMLarissa Aniceto Moreira
Larissa Aniceto Moreira
FBFrederico Gideoni Albinati Batista
Frederico Gideoni Albinati Batista
GMGabriel Galvão Rafael Magalhães
Gabriel Galvão Rafael Magalhães
Objective: Fibrous dysplasia (FD) is a rare bone disorder that can involve any part of the skeleton, leading to bone pain, deformities, and fractures. Treatment with intravenous bisphosphonates has been used with variable results. Therefore, we aimed to evaluate the effects of zoledronic acid (ZA) therapy in patients with monostotic or polyostotic FD. Subjects and methods: The medical records of thirteen patients with FD evaluated between 2015 and 2020 were retrospectively analyzed. In the subgroup of patients treated with [...] ABSTRACT Objective: Fibrous dysplasia (FD) is a rare bone disorder that can involve any part of the skeleton, leading to bone pain, deformities, and fractures. Treatment with intravenous bisphosphonates has been used with variable results. Therefore, we aimed to evaluate the effects of zoledronic acid (ZA) therapy in patients with monostotic or polyostotic FD. Subjects and methods: The medical records of thirteen patients with FD evaluated between 2015 and 2020 were retrospectively analyzed. In the subgroup of patients treated with